New documentary considers the last mile to ‘Ending HIV in America’
A upcoming PBS documentary, “Ending HIV in America,” recounts the history of the AIDS epidemic and looks at how far HIV prevention and treatment efforts have come.
The PROgress project
Preparing patients and doctors for their next visit enhances patient satisfaction and care
When HIV therapy fails: That’s not all, folks
An explanation of some of the technical language in the DHHS’ HIV treatment guidelines
When HIV therapy fails: For treatment-experienced individuals who are experiencing virologic failure
Key considerations and recommendations from the HIV treatment guidelines of the U.S. Department of Health and Human Services (DHHS)
Briefly May+Jun 2022
Cabenuva long-acting injectable no longer requires a month of oral lead-in medication
FDA approves two-month shot of Cabenuva for HIV
FDA has approved Cabenuva, the long-acting injectable regimen, as a shot that can be taken every two months instead of monthly for HIV treatment
12 things to know about HIV treatment
It is recommended that everyone living with HIV be on HIV treatment, and as soon as possible after diagnosis.
In this guide, HIV drugs are grouped into eight categories —plus, additional categories for select non-HIV drugs and PrEP
Editor’s note Mar+Apr 2021
This issue of Positively Aware magazine is our 25th Annual HIV Drug Guide, and it’s been quite a ride.
Taking meds monthly—or possibly once a year
A look at drugs in development for HIV treatment and prevention
Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Dolutegravir during pregnancy
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
HIV meds just four days a week?
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Building blocks for a healthy life
Building blocks for a healthy life, with insights from a nurse educator
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; tenofovir class action lawsuits
Briefly: May+June 2019
New two-drug regimen gets FDA approval. Transgender filmmaker debuts new documentary. Project Inform closes. First kidney transplant from donor living with HIV.
The Conversation: March & April 2019
Mixed emotions for a long-term survivor. Peer education in prison. Loving the HIV drug guides and charts.
Front Cover Backstory: March & April 2019
The experience is your own, but you’re not alone in the room